CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,422 | +89.5% | 10,424 | -62.5% | 0.00% | 0.0% |
| Q2 2022 | $82,000 | +9.3% | 27,810 | +15.7% | 0.00% | – |
| Q1 2022 | $75,000 | -23.5% | 24,042 | -16.7% | 0.00% | -100.0% |
| Q4 2021 | $98,000 | 0.0% | 28,856 | +7.9% | 0.00% | 0.0% |
| Q3 2021 | $98,000 | 0.0% | 26,748 | +56.8% | 0.00% | 0.0% |
| Q4 2020 | $98,000 | +19.5% | 17,061 | +50.3% | 0.00% | 0.0% |
| Q3 2020 | $82,000 | +20.6% | 11,354 | -15.1% | 0.00% | 0.0% |
| Q3 2019 | $68,000 | – | 13,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
| Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
| TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
| COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
| Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
| Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
| Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
| Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
| GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |